Relationship between social and cognitive functions in people with schizophrenia

QR Code

Relationship between social and cognitive functions in people with schizophrenia

Takeo Tominaga,1 Masahito Tomotake,2 Tomoya Takeda,1 Yoshinori Ueoka,3 Tsunehiko Tanaka,4 Shin-ya Watanabe,1 Naomi Kameoka,5 Masahito Nakataki,5 Shusuke Numata,1 Yumiko Izaki,6 Satsuki Sumitani,7 Hiroko Kubo,8 Yasuhiro Kaneda,9 Tetsuro Ohmori1 1Department of Psychiatry, Graduate School of Biomedica...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Tominaga T, Tomotake M, Takeda T, Ueoka Y, Tanaka T, Watanabe SY, Kameoka N, Nakataki M, Numata S, Izaki Y, Sumitani S, Kubo H, Kaneda Y, Ohmori T
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2018
Sujets:	schizophrenia social function negative symptom cognitive function speed of processing Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/9ca7b45da43542cbb4f8b97d89702607
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia
par: Takeda T, et autres
Publié: (2019)

Cariprazine: Patients with Treatment-Resistant Schizophrenia
par: Aubel T
Publié: (2021)

Elevated activity of superoxide dismutase in male late-life schizophrenia and its correlation with clinical symptoms and cognitive deficits
par: Lijuan Huo, et autres
Publié: (2021)

Cognitive dysfunction and negative symptoms in patients with schizophrenia and their first-degree relatives from simplex and multiplex families
par: Zhang Z, et autres
Publié: (2018)

Effectiveness of amisulpride in Chinese patients with predominantly negative symptoms of schizophrenia: a subanalysis of the ESCAPE study
par: Liang Y, et autres
Publié: (2017)

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms
par: Octavian Vasiliu
Publié: (2021)

Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment
par: Aleksandr M. Reznik, et autres
Publié: (2020)

Clinical factors influencing resilience in patients with anorexia nervosa
par: Kane C, et autres
Publié: (2019)

Adjunctive simvastatin treatment in schizophrenia patients; a double blind randomized and placebo controlled trial
par: Somaieh Ashrafi, et autres
Publié: (2022)

Metacognitive Beliefs, Cognitive Functioning, Psychiatric Symptoms and Empathy in People with Schizophrenia
par: Chuang SP, et autres
Publié: (2021)

Structural equation modeling approach between salience network dysfunction, depressed mood, and subjective quality of life in schizophrenia: an ICA resting-state fMRI study
par: Ohta M, et autres
Publié: (2018)

The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia
par: Urban-Kowalczyk M, et autres
Publié: (2021)

Reliability of the performance-based measure of executive functions in people with schizophrenia
par: En-Chi Chiu, et autres
Publié: (2021)

Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience
par: Montes JM, et autres
Publié: (2021)

Influence of CFH gene on symptom severity of schizophrenia
par: Zhang C, et autres
Publié: (2017)

Short-term functional outcome in psychotic patients: results of the Turku early psychosis study (TEPS)
par: Raimo K. R. Salokangas, et autres
Publié: (2021)

Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment
par: Correll CU, et autres
Publié: (2020)

Online Left-Hemispheric In-Phase Frontoparietal Theta tACS for the Treatment of Negative Symptoms of Schizophrenia
par: Chuan-Chia Chang, et autres
Publié: (2021)

Heart Rate Variability in Schizophrenia and Autism
par: Sarah M. Haigh, et autres
Publié: (2021)

Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
par: Zhuo K, et autres
Publié: (2019)

BDNF, GDNF, NGF and Klotho levels and neurocognitive functions in acute term of schizophrenia
par: Betul Aslan Turkmen, et autres
Publié: (2021)

The Effects of Recreation Therapy on the Habit of Smoking and Positive–Negative Symptoms Among Patients with Chronic Schizophrenia
par: Pirbalouti M. G., et autres
Publié: (2017)

Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia
par: Urban-Kowalczyk M, et autres
Publié: (2016)

Pilot Validation Study of the Japanese Translation of the Brief Negative Symptoms Scale (BNSS)
par: Hashimoto N, et autres
Publié: (2019)

Validation of the Chinese Version of the 16-Item Negative Symptom Assessment
par: Huang B, et autres
Publié: (2020)

Association of Cognitive Impairment With Anhedonia in Patients With Schizophrenia
par: Lingfang Yu, et autres
Publié: (2021)

Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
par: Ping Yin, et autres
Publié: (2021)

Suicidality, self-stigma, social anxiety and personality traits in stabilized schizophrenia patients – a cross-sectional study
par: Vrbova K, et autres
Publié: (2018)

Validation of the Chinese version of Brief Assessment of Cognition in Schizophrenia
par: Wang LJ, et autres
Publié: (2016)

Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia
par: Ohnishi T, et autres
Publié: (2021)

Schizophrenia and reelin: a model based on prenatal stress to study epigenetics, brain development and behavior
par: Negrón-Oyarzo,Ignacio, et autres
Publié: (2016)

Magnetic Seizure Therapy Compared to Electroconvulsive Therapy for Schizophrenia: A Randomized Controlled Trial
par: Jiangling Jiang, et autres
Publié: (2021)

Increased Plasma Kynurenic Acid Levels are Associated with Impaired Attention/Vigilance and Social Cognition in Patients with Schizophrenia
par: Huang X, et autres
Publié: (2020)

Validation of the Dutch Version of the Brief Negative Symptom Scale
par: Seelen-de Lang BL, et autres
Publié: (2020)

Cortical thinning and flattening in schizophrenia and their unaffected parents
par: Yan J, et autres
Publié: (2019)

The NCAN gene: schizophrenia susceptibility and cognitive dysfunction
par: Wang P, et autres
Publié: (2016)

Eye Movements and Cognitive Functioning in Patients With Schizophrenia Spectrum Disorders: Network Analysis
par: Alexander Shmukler, et autres
Publié: (2021)

Associations Of Personality Traits With The Capacity-Performance Discrepancy Of Functional Outcome In Patients With Schizophrenia
par: Uchino T, et autres
Publié: (2019)

Schizophrenia and toxoplasmosis: association with catatonic symptoms
par: Dmitry V. Romanov, et autres
Publié: (2020)

A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study
par: Li Y, et autres
Publié: (2021)